US Senator Seeks Clarifications from FDA About Neuralink Inspection
Tuesday, 26 March 2024, 10:19
Exclusive – US lawmaker seeks answers on FDA inspection of Musk's Neuralink
By Marisa Taylor WASHINGTON - A U.S. lawmaker involved in health policy has asked the Food and Drug Administration why it did not inspect Elon Musk's Neuralink before allowing the brain implant company to test its device in humans. Reuters reported the senator's concerns over the FDA's regulatory process and the implications for innovative medical technologies.
This article was prepared using information from open sources in accordance with the principles of Ethical Policy. The editorial team is not responsible for absolute accuracy, as it relies on data from the sources referenced.